Wendy Stock to Killer Cells, Natural
This is a "connection" page, showing publications Wendy Stock has written about Killer Cells, Natural.
Connection Strength
0.048
-
Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy. J Clin Invest. 2000 Jul; 106(1):117-24.
Score: 0.040
-
A phase II trial of interleukin-2 in myelodysplastic syndromes. Br J Haematol. 1998 Apr; 101(1):205-7.
Score: 0.008